Matthew J. Hadfield

Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study

Guihong Wan, Wenxin Chen, Sara Khattab et al. · The Lancet Oncology · 2024 · 90 citations · Full text

Life Sciences, Immunology, Oncology +17

Harnessing artificial intelligence for prostate cancer management

Lingxuan Zhu, Jiahua Pan, Weiming Mou et al. · Cell Reports Medicine · 2024 · 56 citations · Full text

Medicine, Pathology, Urology +17

Pharmacist intervention in colorectal cancer screening initiative

Lisa M. Holle, Joel S. Levine, Thomas Buckley et al. · Journal of the American Pharmacists Association · 2020 · 32 citations

Medicine, Clinical Pharmacy, Pharmacy Practice +10

Final results of BrUOG 354: A randomized phase II trial of nivolumab alone or in combination with ipilimumab for people with ovarian and other extra-renal clear cell carcinomas.

Don S. Dizon, Cara Mathews, Shannon MacLaughlan David et al. · Journal of Clinical Oncology · 2024 · 27 citations

Medicine, Gynecology, Oncology +16

Current and Emerging Therapeutic Targets for the Treatment of Cholangiocarcinoma: An Updated Review

Matthew J. Hadfield, Kathryn DeCarli, Kinan Bash et al. · International Journal of Molecular Sciences · 2023 · 19 citations · Full text

Medicine, Immunology, Oncology +14